http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Psychostimulants were associated with statistically significant improvement in depressive symptoms in major depressive disorder (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.13-1.78; P = 0.003) and bipolar disorder (OR, 1.42; 95% CI, 1.13-1.78; P = 0.003). Efficacy outcomes differed across the psychostimulants evaluated as a function of response rates: ar/modafinil (OR, 1.47; 95% CI, 1.20-1.81; P = 0.0002); dextroamphetamine (OR, 7.11; 95% CI, 1.09-46.44; P = 0.04); lisdexamfetamine dimesylate (OR, 1.21; 95% CI, 0.94-1.56; P = ns); methylphenidate (OR, 1.49; 95% CI, 0.88-2.54; P = ns). Efficacy outcomes also differed between agents used as adjunctive therapy (OR, 1.39; 95% CI, 1.19-1.64) or monotherapy (OR, 2.25; 95% CI, 0.67-7.52).

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0002009 MONDO_0002009

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://go.drugbank.com/drugs/DB01576 DB01576

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RA71ceCS4_...#cohort cohort

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/28590365/ pubmed.ncbi.nlm.nih.gov/28590365

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-05-26T14:50:07.672Z

http://purl.org/np/RA71ceCS4_... RA71ceCS4_

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-05-26T14:50:07.672Z